The article about risk-based monitoring that I mentioned a couple of weeks ago is now online. “Adaptive Monitoring: Risk-Based Monitoring and Beyond” appears in the September issue of the Journal of Clinical Research Best Practices. Norman Goldfarb, the editor, keeps a close eye on trends in clinical development. He had this to say about the article and the Health Decisions approach to running clinical trials:
If 100% source data verification is the first generation and risk-based monitoring the second generation, Dr. Rosenberg’s system of “Agile Clinical Development” is probably the fourth generation—and it’s operating today. Our mission is to advance the practice of clinical research and Dr. Rosenberg’s insights into the future of risk-based monitoring do exactly that.
It’s nice to have additional independent and authoritative validation of the Health Decisions approach not long after accepting the 2013 CIO 100 Award for our adaptive monitoring technology. For additional background on the article and the Journal of Clinical Research Best Practices, please see our press release .